The global health organization had suspended the study over concerns about the drug’s side effects
In the meanwhile, other studies are looking at whether the drug might be effective if used earlier in the disease progression. So far, the results from these studies are not very promising. On the same day that the WHO resumed its trial, U.S. and Canadian researchers reported in athat hydroxychloroquine did not seem to protect people at high risk of infection from getting COVID-19.
Dr. Radha Rajasingham, assistant professor of medicine at University of Minnesota and another co-author of the study, says “Hydroxychloroquine should not be used as post-exposure prophylaxis for COVID-19.”
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
WHO set to resume hydroxychloroquine trial in battle against COVID-19The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
Weiterlesen »
WHO committee recommends continued study of hydroxychloroquine as a potential Covid-19 treatmentThe coronavirus pandemic has brought countries to a standstill. Here's the latest updates on Covid-19 cases, deaths, government responses and more.
Weiterlesen »
No Evidence Hydroxychloroquine Is Helpful In Preventing COVID-19, Study FindsA study of more than 800 health workers, first responders and others finds that taking hydroxychloroquine to prevent COVID-19 is no better than a placebo in preventing the illness.
Weiterlesen »
WHO set to resume hydroxychloroquine trial in battle against COVID-19The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
Weiterlesen »
Shortages of Hydroxychloroquine for Lupus PatientsMore than one-third of U.S. lupus patients who take hydroxychloroquine have struggled to fill prescriptions for the drug during the COVID-19 crisis, a new survey finds.
Weiterlesen »